Without Additional Funding, US FDA's Inspections In Jeopardy – Regulatory Affairs Chief

Without additional funding, FDA’s ORA faces challenges in retaining and hiring staff, which will impact inspections, says office chief Michael Rogers. 

• Source: Shutterstock

The US Food and Drug Administration will not keep up with inspections if it doesn’t receive additional funding in fiscal year 2025 to help the Office of Regulatory Affairs with retaining and hiring staff, says Michael Rogers, associate commissioner for regulatory affairs.

During an Alliance for a Stronger FDA webinar on 1 May webinar, Rogers said not receiving the $46m in the...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Regulation

More from Policy & Regulation